IRWD Ironwood Pharmaceuticals PE ratio, current and historical analysis
The current PE ratio of IRWD can't be determined, as the TTM EPS of -$0.02 is negative. Ironwood Pharmaceuticals's last PE ratio on record was 108.67 in June 2024.
IRWD PE ratio history
The mean historical PE ratio of Ironwood Pharmaceuticals over the last six years is 22.46. Over the past six years, IRWD's PE ratio was at its highest in the Jun 2024 quarter at 108.67, with a price of $6.52 and an EPS of $0.06. The Dec 2021 quarter recorded the bottom point at 3.58, with a price of $11.66 and an EPS of $3.26.
Ironwood Pharmaceuticals PE ratio by year
Maximum annual increase: 206.15% in 2022
Maximum annual decrease: -82.12% in 2020
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2023 | N/A | N/A | $11.44 | -$6.45 |
| 2022 | 10.96 | 206.15% | $12.39 | $1.13 |
| 2021 | 3.58 | -78.94% | $11.66 | $3.26 |
| 2020 | 17 | -82.12% | $11.39 | $0.67 |
| 2019 | 95.07 | N/A | $13.31 | $0.14 |
| 2018 | N/A | N/A | $10.36 | -$1.85 |
| 2017 | N/A | N/A | $14.99 | -$0.78 |
| 2016 | N/A | N/A | $15.29 | -$0.56 |
| 2015 | N/A | N/A | $11.59 | -$1 |
| 2014 | N/A | N/A | $15.32 | -$1.39 |
| 2013 | N/A | N/A | $11.61 | -$2.35 |
| 2012 | N/A | N/A | $11.08 | -$0.68 |
| 2011 | N/A | N/A | $11.97 | -$0.65 |
| 2010 | N/A | N/A | $10.35 | -$0.59 |
| 2009 | N/A | N/A | N/A | -$10 |
Ironwood Pharmaceuticals PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Sep 2024 | N/A | N/A | $4.12 | -$0.02 |
| Jun 2024 | 108.67 | N/A | $6.52 | $0.06 |
| Mar 2024 | N/A | N/A | $8.71 | -$6.77 |
| Dec 2023 | N/A | N/A | $11.44 | -$6.45 |
| Sep 2023 | N/A | N/A | $9.63 | -$6.13 |
| Jun 2023 | N/A | N/A | $10.64 | -$5.9 |
| Mar 2023 | 8.92 | -18.61% | $10.52 | $1.18 |
| Dec 2022 | 10.96 | 13.22% | $12.39 | $1.13 |
| Sep 2022 | 9.68 | -9.36% | $10.36 | $1.07 |
| Jun 2022 | 10.68 | 176.68% | $11.53 | $1.08 |
| Mar 2022 | 3.86 | 7.82% | $12.58 | $3.26 |
| Dec 2021 | 3.58 | -10.05% | $11.66 | $3.26 |
| Sep 2021 | 3.98 | -2.21% | $13.06 | $3.28 |
| Jun 2021 | 4.07 | -67.23% | $12.87 | $3.16 |
| Mar 2021 | 12.42 | -26.94% | $11.18 | $0.9 |
IRWD average PE ratio chart
IRWD PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| AZN Astrazeneca plc | 32.7 | $230.16B |
| CPIX Cumberland Pharmaceuticals Inc | N/A | $74.56M |
| NKTR Nektar Therapeutics | N/A | $171.95M |
| IRWD Ironwood Pharmaceuticals Inc | N/A | $290.45M |
Frequently asked questions
What is Ironwood Pharmaceuticals's PE ratio?
The current price to earnings ratio of IRWD can't be calculated, as its EPS of -$0.02 is negative.
What is the 3-year average PE ratio for Ironwood Pharmaceuticals (IRWD)?
Over the last 3 years, the average price to earnings ratio for IRWD stock is 25.46.
What is the 5-year average PE ratio for Ironwood Pharmaceuticals (IRWD)?
Over the last 5 years, the average price to earnings ratio for IRWD stock is 17.27.
What is the highest PE ratio for IRWD?
In the last six years, the Jun 2024 quarter recorded the highest quarterly PE ratio at 108.67.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.